Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The nine lives of epitope-based antibody patents

The nine lives of epitope-based antibody patents Epitope-based antibody claims have emerged to become one of the most important claim species in antibody patents. At the same time, they are heavily disputed. This article strives to give an overview about the as is situation both in Europe and the United States. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Human Antibodies IOS Press

The nine lives of epitope-based antibody patents

Storz, Ulrich
Human Antibodies , Volume 28 (2): 22 – Jul 9, 2020
Download PDF
22 pages

Loading next page...
 
/lp/ios-press/the-nine-lives-of-epitope-based-antibody-patents-10leSKDIwZ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
IOS Press
Copyright
Copyright © 2020 © 2020 – IOS Press and the authors. All rights reserved
ISSN
1093-2607
eISSN
1875-869X
DOI
10.3233/HAB-190395
Publisher site
See Article on Publisher Site

Abstract

Epitope-based antibody claims have emerged to become one of the most important claim species in antibody patents. At the same time, they are heavily disputed. This article strives to give an overview about the as is situation both in Europe and the United States.

Journal

Human Antibodies – IOS Press

Published: Jul 9, 2020

There are no references for this article.